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Most researchers agree that idiopathic scoliosis (IS) is a multifactorial disease influenced by complex genetic and environmental
factors. The onset of the spinal deformity that determines the natural course of the disease, usually occurs in the juvenile or
adolescent period. Transforming growth factors 𝛽 (TGF-𝛽s) and their receptors, TGFBRs, may be considered as candidate genes
related to IS susceptibility and natural history. This study explores the transcriptional profile of TGF-𝛽s, TGFBRs, and TGF-𝛽
responsive genes in the paravertebral muscles of patients with juvenile and adolescent idiopathic scoliosis (JIS and AIS, resp.).
Muscle specimens were harvested intraoperatively and grouped according to the side of the curve and the age of scoliosis onset.The
results ofmicroarray andqRT-PCRanalysis confirmed significantly higher transcript abundances of TGF-𝛽2, TGF-𝛽3, andTGFBR2
in samples from the curve concavity of AIS patients, suggesting a difference in TGF-𝛽 signaling in the pathogenesis of juvenile and
adolescent curves. Analysis of TGF-𝛽 responsive genes in the transcriptomes of patients with AIS suggested overrepresentation
of the genes localized in the extracellular region of curve concavity: LTBP3, LTBP4, ITGB4, and ITGB5. This finding suggests the
extracellular region of paravertebral muscles as an interesting target for future molecular research into AIS pathogenesis.
1. Introduction
Scoliosis is the most common spinal deformity in humans.
Changes in spinal shape are three-dimensional and can be
described as lateral curvature in the frontal plane, thoracic
lordosis in the sagittal plane, and axial rotation in the
horizontal plane. About 20% of scoliosis represent a phe-
notypic expression accompanying various pathologic condi-
tions originating in almost every human tissue. The remain-
ing 80% are idiopathic curves. Although the etiopathogenesis
of idiopathic scoliosis (IS) is still unknown, there is an
agreement about the multifactorial nature of this disorder [1–
4]. A genetic model with two sets of genes, one responsible
for the initiation and the other for the curve progression, well
illustrates the multifactorial nature of IS. These genes could
act separately or interact under the influence of diverse envi-
ronmental and epigenetic factors [3, 5, 6]. The result of these
complex interactions is the high heterogeneity of morpho-
logic types, differences in the progression potential and the
ages at presentation of the idiopathic curves. Paravertebral
muscles play an essential role in the control of spinal stability
[7, 8]. Imbalance of the paravertebral muscles could lead to
biomechanical instability resulting in the development of a
scoliotic curve. In addition, differences in progression among
individuals may stem from divergence in muscle activation
strategies or an inherent deficiency in structure and func-
tion of these muscles [9]. The Transforming growth factor-
𝛽 (TGF-𝛽) superfamily consists of a variety of cytokines
expressed inmany different tissues including skeletal muscles
[10]. Expression of these molecules is linked to normal
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processes such as growth, differentiation, regeneration, and
the stress response. TGF-𝛽 signaling is also required for cell
regulation, angiogenesis, apoptosis, migration, extracellular
matrix (ECM) remodeling and embryonic development [10–
12]. TGF-𝛽1 is one of the candidate genes in osteoporosis,
and decreased bone mineral density (BMD) was observed
in 27–68% of children with IS [13–18]. Osteopenia has
also been suggested as one of the progression risk factors
of IS [19, 20]. TGF-𝛽1–3 isoforms are encoded by three
different genes located respectively on chromosomes 19q13,
1q41, and 14q24 [11, 12]. Activated dimerized TGF-𝛽 proteins
bind to cell-surface receptors type 1 and 2 (TGFBR1 and
TGFBR2); transmembrane serine/threonine specific kinases
that interact and phosphorylate intracellular molecules [21].
TGF-𝛽 ligands can also interactwith the coreceptors endoglin
and betaglycan, known as TGFBR3 [11]. Both endoglin and
betaglycan can present TGF-𝛽s to the TGFBR2 which then
complexes with and phosphorylates TGFBR1 [21]. TGFBR3 is
especially important for the TGF-𝛽2 isoform, which, because
of its low affinity, requires the presence of TGFBR3 to form
a complex with TGFBR2 [22, 23]. Intracellular signaling of
TGF-𝛽s is mediated by proteins of Smads family. Smads 2
and 3 are substrates for receptors activated by TGF-𝛽s and
activins. Smads 1, 5, and 8 are downstream effectors for recep-
tors activated by BMPs, GDFs, and MIFs. Phosphorylated
Smads 1, 2, 3, 5, and 8 associate with Smad 4 and these
complexes translocate to the nucleus, where together with
other transcription factors they regulate the transcription
of target genes [11, 24]. In addition to the canonical Smad
pathway TGF-𝛽s also signal through noncanonical path-
ways including mitogen activated kinase (MAPK), nuclear
factor 𝜅-B (NF-𝜅-B), Rho-like GTPase, phosphoinositide 3-
kinase (PI3K)/Akt, hypoxia/hypoxia-inducible factor-1 (HIF-
1) pathways [10, 11, 25]. Abnormalities in TGF-𝛽 signaling
play an important role in various inherited and acquiredmus-
culoskeletal disorders where scoliotic deformity of the axial
skeleton is one of the important clinical features. Progressive
scoliosis occurs in approximately 45 to 60% of patients
with Marfan syndrome (MFS) [26]. MFS is an autosomal
dominant systemic disorder of connective tissue, caused by
mutation of the FBN1 gene, which encodes extracellular
matrix protein fibrillin-1 [10]. Fibrillin-1 stabilizes the Latent
TGF-𝛽 complexes in the extracellular matrix. The various
symptoms of Marfan syndrome are considered to be the
result of an overall abnormality in the homeostasis of the
extracellular matrix in which mutated forms of fibrillin-1
have led to alterations in mechanical properties of tissues,
increased TGF-𝛽 signaling, and loss of appropriate cell-
matrix interactions [24]. Marfan-like phenotypes may be
also caused by mutations in TGF-𝛽 receptors. Scoliosis can
be found in 46% of patients with Loeys-Dietz syndrome;
a multisystem disease caused by a mutation in the genes
encoding TGFBR1 or TGFBR2 [27]. Mutations of the gene
encoding the TGF-𝛽1 protein cause Camurati-Engelmann
disease, which is associated with marfanoid habitus and
increased TGF-𝛽 signaling, despite the absence of connec-
tive tissue fragility [28]. Increased TGF-𝛽 activity is also
involved in the pathogenesis of muscular dystrophies charac-
terized by variable progressive muscle weakness and wasting.
In the most common form, Duchenne muscular dystrophy
(DMD) mutations in the dystrophin gene lead to the loss
of protection from contraction-induced injury. The resulting
myocyte necrosis increases TGF-𝛽 signaling, which promotes
muscle fibrosis at the expense of regeneration by satellite cells
[29, 30]. Patients with DMDhave a 90% chance of developing
significant progressive scoliosis [31]. Despite many decades
of multidisciplinary research, the cause(s) of IS remains
unknown. The rapidly evolving arsenal of diagnostic and
research tools offered by contemporary science allowed us to
not only investigate 3-D deformity of IS not only through the
radiological prism to determine changes in the spinal shape,
but also to make an attempt at evaluating IS at the molecular
level. In the last decade the number of studies investigating
the molecular basis of IS has greatly increased. Much of the
research work has focused on the identification of candidate
genes related to connective tissue structure, bone formation
and metabolism, melatonin signaling, puberty and growth,
and axon guidance pathways [32]. Recently, in a case-control
study, functional polymorphisms of the TGF-𝛽1 gene were
reported to be significantly associated with AIS susceptibility.
In the female population, TGF-𝛽1 polymorphism −509C > T
also appeared to be associated with the age of disease onset
and curve severity [33].Most of idiopathic scoliotic curves are
diagnosed during the juvenile or adolescent period [34]. The
age of scoliosis onset determines its epidemiology, natural
course and response to the treatment to a large extent [35–
38]. Juvenile curves represent 12–21% of all scoliosis with
unknown etiology [17, 35, 36, 39]. Curve morphologies are
similar in both types of scoliosis, with the predomination of
right primary thoracic and double primary thoracolumbar
curves [37, 39]. The risk of deformity progression is the most
important factor discriminating the juvenile type from the
adolescent type of scoliosis. Patients with juvenile curves
more often present with severe progression and 27% to 80%
require operative treatment. In AIS, the risk of progression is
much lower and only 0,1% of patients are operated on [35–38,
40, 41]. The reason(s) for different ages of scoliosis onset and
associated differences in natural history are unknown. The
results of a heritability study of 69 extended families in Utah
with a history of AIS show that the onset of AIS is inherited
separately from curve pattern and severity [42]. It also seems
that genetic markers of progression in the adolescent type do
not apply to idiopathic scoliosis with an early onset, below 9
years of age [43]. IS is presumed to be a multifactorial disease
that is influenced by complex genetic and environmental
factors. It is likely that curves with an earlier onset may
have a different genetic background to curves appearing in
adolescence. TGF-𝛽s and their receptors may be included in
the group of candidate genes involved in the etiology and
pathogenesis of IS. Changes in the transcriptional profile
of TGF-𝛽s and their receptors (TGFBRs) could affect the
expression of TGF-𝛽 responsive genes [44]. This could
influence the regulation of a variety of signal transduction
pathways potentially involved in IS etiopathogenesis. This
involvement of TGF-𝛽 signaling could differ in juvenile and
adolescent types of IS. Although TGF-𝛽s and their receptors
may be considered as candidate genes potentially related to
IS susceptibility and natural history, so far nothing is known
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about the expression of these genes in the muscular tissue of
IS patients. Therefore, the main aims of this study were.
(1) Evaluation of the transcriptional activity of TGF-𝛽1,
TGF-𝛽2, and TGF-𝛽3 and their receptors TGFBR1,
TGFBR2, and TGFBR3, in paravertebral muscles on
both sides of the scoliotic curve in JIS and AIS.
(2) Identification of the TGF-𝛽 responsive genes differen-
tiating between the concave and convex sides of the
scoliotic curve in juvenile and adolescent idiopathic
scoliosis.
2. Materials and Methods
2.1. Material. The study design was approved by the Bio-
ethical Committee Board of Silesian Medical University.
Informed, written consent was obtained from each patient
participating in the study and if required from their parents.
Nine female patients average age 17.9 (13.4 to 25 years old),
with a definite diagnosis of IS were included in the study.
Five of the girls had a scoliotic curve diagnosed before
the age of 10, and were designated as group A—juvenile
idiopathic scoliosis, and four after 10 years of age, designated
as group B—Adolescent Idiopathic Scoliosis. All of the
patients had undergone posterior corrective surgery by theC-
D method. According to the Lenke classification two curves
were of type 2, four curves of type 3, two curves of type 5,
one of type 6 [45]. Preoperatively, the average frontal and
sagittal Cobb angles measured on standard p-a, and lateral
radiograms were 67.3∘ (range 36∘–94∘) and 37∘ (range 20∘–
55∘), respectively. Axial plane deformity was measured on
computed tomography (CT) scans performed at the curve
apex by spinal rotation angle relative to the sagittal plane
(RAsag) and rib hump index (RHi), as described by Aaro and
Dahlborn [46].Themean RAsag was 19∘ (range 2.5∘–36∘) and
RHi was 0.41 (range 0.03–0.74). Eighteen paravertebral tissue
samples were collected intraoperatively; 9 from the concave
(M1) and 9 from the convex (M2) side of the curve apex. One
sample from concave and one sample from convex side of the
curve were lost for further investigation in each of the studied
groups (4 samples). Details of the participants in each of the
studied group are listed in Table 1.
2.2. Molecular Analysis. Fourteen total RNA samples were
submitted for gene expression analysis to determine the
expression of TGF-𝛽 isoforms and their receptors TGFBRs
with the use of HGU 133A oligonucleotide microarrays
(Affymetrix) and qRT-PCR. Microarray data were further
analyzed to identify TGF-𝛽 responsive genes differentially
expressed between the concave and the convex sides of
the curve in group A-JIS and group B-AIS. Extraction of
total RNA from paravertebral muscles tissue samples was
performed as described in a previous study [47]. Total RNA
served as a matrix for microarray and qRT-PCR analysis of
14 transcriptomes. Muscular tissue samples preparation and
HGU 133A microarray processing was performed according
to Affymetrix Gene Expression Analysis Technical Manual.
Details of the microarray processing were described pre-
viously [47]. Every step of the paravertebral muscle tran-
scriptome processing method was verified qualitatively by
electrophoresis on a 1% agarose gel stained with ethid-
ium bromide and quantitatively by absorbance at 260 nm
using a Gene Quant II spectrophotometer (Pharmacia LKB
Biochrom Ltd.). After hybridization, fluorescence intensity
was measured with an Agilent Gene Array Scanner G2500A
(Affymetrix). After the microarrays were deemed suitable
for comparative analysis, the fluorescence intensity values
of all 22 843 transcripts of the 14HG U133A chips were
simultaneously normalized with the use of robust multichip
average (RMA) algorithm [48]. The first step of the microar-
ray analysis relied on a comparison of the fluorescence signals
intensities of 10 mRNA IDs complementary to HGU 133A
microarray probes between the paravertebral muscles of the
concave and the convex side of the curve in JIS and AIS:
three for TGF-𝛽2, two for TGF-𝛽1, two for TGFBR2, and one
for each of TGF-𝛽3, TGFBR1, and TGFBR3. The results of
themicroarray experiment were validated by qRT-PCR. Total
RNA extracted from 14 paravertebral tissue samples served as
a matrix for qRT-PCR of TGF-𝛽1, TGF-𝛽2, TGF-𝛽3 mRNA
and that of their receptors: TGFBR1, TGFBR2, and TGFBR3.
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and
𝛽-actin (ACTB) mRNA served as endogenous controls. The
quantitative analysis was carried out with the use of a
Sequence Detector ABI PRISM 7000 (Applied Biosystems).
A standard curve was constructed for standards of ACTB
(TaqMan DNA Template Reagents Kit, Applied Biosystems)
and mRNA abundance in all tissue specimens was expressed
as mRNA copy number per 1 𝜇g of total RNA. Details of the
qRT-PCR method and the sequence of PCR primers were
described in previous studies [49, 50].
Statistical analysis of the microarray results was per-
formed with a GeneSpring 11 GX application (Agilent Tech-
nologies). Statistical analysis of the qRT-PCR results was
performed with Statistica Version 10 software (StatSoft).
Quantitative data were compared using a two-way ANOVA,
and a nonparametricMannWhitney𝑈 test, and𝑃 < 0.05was
considered statistically significant. Selected differentiating
genes were classified by their gene ontology (GO) and
analyzed statistically with the use of an overrepresentation
test in a web-based, open access PANTHER database [51].
The microarray data from this experiment are publically
available in MIAME-compliant format from the following
address: http://www.ebi.ac.uk/arrayexpress/, the file ID is E-
MTAB-980.
3. Results
Paravertebral muscles transcriptomes were grouped accord-
ing to the side of the curve (M1—curve concavity, M2—
curve convexity) and the age of scoliosis onset (A-juvenile
idiopathic scoliosis, B-adolescent idiopathic scoliosis). Dif-
ferentiation of the transcriptomes was evaluated in three
steps. In the first step, TGF-𝛽s and TGFBRs mRNA IDs
were differentiated by oligonucleotidemicroarray chipsHGU
133A (Affymetrix). In the second step, the microarray results
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Table 1: Characteristics of patients of both studied groups. Group A: Juvenile idiopathic scoliosis, group B: adolescent idiopathic scoliosis.
M1, M2 samples from curve concavity and convexity. RAsag: rotation angle sagittal, RHindex: rib hump index.
Patient Sample Group Lenke type Cobb angle Kyphosis angle RAsag RHindex
K.P. M2 A 3 68 33 14 0.48
F.J. M1, M2 A 3 94 50 24 0.56
B.P. M1 A 6 36 48 2.5 0.03
R.K. M1, M2 A 2 60 34 17 0.36
N.M. M1, M2 A 5 75 30 21.5 0.5
M.S. M1 B 3 66 30 6 0.03
J.K. M2 B 2 88 55 29 0.64
P.A. M1, M2 B 5 42 40 21 0.3
W.P. M1, M2 B 3 77 20 36 0.7
TGF𝛽1
TGF𝛽1
TGF𝛽2
TGF𝛽2
TGF𝛽2
TGF𝛽3
TGFBR1
TGFBR2
TGFBR2
TGFBR3
[M1, A] [M1, B] [M2, A] [M2, B]
Color range
−1.6 0 1.6
Figure 1: Heat map of fluorescence signal intensities of TGFB 1–3 and TGFBRs 1–3. Heat map of fluorescence signals intensities of 10 mRNA
IDs of genes encoding TGF-𝛽 1–3 and their receptors TGFBR 1–3 in paravertebral muscles of curve concavity (M1) and curve convexity (M2)
in a group of juvenile (A) and adolescent idiopathic scoliosis (B).
were validated of the by qRT-PCR. Finally, 1050 mRNA
IDs of 530 genes connected with TGF-𝛽 biological activity
were selected based on Affymetrix data, and analysis of the
expression profile of their transcriptomes was performed
with the microarray data in order to select candidate genes
differentiating paravertebral muscles from curve concavity
and convexity in JIS and AIS.
3.1. Evaluation of TGF-𝛽s and TGFBRs Expression in the
Paravertebral Muscles of JIS and AIS Patients Using HG
U133A Microarrays. Preliminary assessment of the mRNA
fluorescence signal dispersion of the analyzed transcripts was
performed with a heat map generated in GeneSpring 11 GX
application. The heat map displays the normalized signal
values, permitting the comparison of the transcriptional
activity of the TGF-𝛽s and TGFBRs in relation to the
average transcriptional activity of paravertebral muscles. The
expression value of each gene is mapped to a color-intensity
value. Yellow indicates an average level of specific mRNA
abundance in the analyzed transcriptomes. An increase in the
mRNA abundance compared to the average value correlates
with a change towards the red colors and decrease with a
change towards the blue. Differentiation of the colors seen on
the generated heat map indicates that transcriptional profile
of the analyzed samples changeswith the age of scoliosis onset
(group A and B) and the side of the scoliotic curve (M1 and
M2), as shown in Figure 1. Subsequent fold change analysis of
differences in expression between the analyzedmRNAgroups
was performed with a nonparametric 𝑈 Mann-Whitney test
with permutative 𝑃-value computation. A fold change with
a cutoff ≥ 1.1 and 𝑃 < 0.05 was assumed to be statistically
significant (Table 2).
Statistically significant differences in fluorescence signal
intensity between the concave and convex paravertebral
muscle transcriptomes were found for TGF-𝛽2, TGF-𝛽3 and
TGFBR2 mRNA probes only in group B-AIS.
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Table 2: Comparison of fluorescence signal intensity of mRNA IDs of TGFBs and TGFBRs in paravertebral muscle transcriptomes from
curve concavity (M1) and convexity (M2) in JIS (group A) and AIS (group B) patients.
Group ID Symbol NCBI-ID Mann-Whitney FC Regulation
A (M1 versus M2)
203085 s at TGF-𝛽1 7040 NS 1.3 Up
204731 at TGFBR3 7049 NS 1.1 Up
206943 at TGFBR1 7046 NS 1.1 Down
209908 s at TGF-𝛽2 7042 NS 1.1 Down
B (M1 versus M2)
207334 s at TGFBR2 7048 0.009 1.1 Up
209747 at TGF-𝛽3 7043 0.014 1.1 Up
209908 s at TGF-𝛽2 7042 0.016 1.2 Up
Table 3: Comparison of the qRT-PCR transcriptional profile of TGFBs and TGFBRs in paravertebral muscles of the concave (M1) and convex
(M2) sides of the curve in JIS (group A) and AIS (group B) patients.
Group 𝑃 value nonparametric 𝑈Mann-Whitney test
TGF-𝛽1 TGF-𝛽2 TGF-𝛽3 TGFBR1 TGFBR2 TGFBR3
A (M1 versus M2) 0.492 0.958 0.313 0.562 0.683 0.022
B (M1 versus M2) 0.683 0.0044 0.048 0.157 0.0109 0.214
3.2. qRT-PCR Evaluation of the Transcriptional Profile of TGF-
𝛽s and TGFBRs in Paravertebral Muscles of JIS and AIS
Patients. qRT-PCR was used to evaluate the transcriptional
profile of TGF-𝛽1–3 and their receptors, TGFBR1–3 in the
paravertebral muscles of patients with JIS and AIS. The
abundance of TGF-𝛽s and TGFBRs mRNA in the concave
(M1) and convex (M2) sides of the curve in groups A and B
confirmed the results of the HGU 133A microarray experi-
ment. Significantly higher abundances of TGF-𝛽2, TGF-𝛽3
and TGFBR2 mRNA (nonparametric 𝑈Mann-Whitney test,
𝑃 < 0.05) on the concave side of the curve were found in
group B. In group A, a statistically significant difference in
the abundance of TGFBR3 mRNA was found, however, this
was not confirmed by the preceding microarray experiment
(Table 3, Figure 2).
3.3. Transcriptional Profile of TGF-𝛽 Responsive Genes. Dif-
ferences in the expression of TGF-𝛽 responsive genes
between the paravertebral muscles of the concave and convex
sides of the curve were evaluated in groups A and B. 1050
mRNA IDs of TGF𝛽-associated genes were selected from
22843 transcripts that could be analyzed with HGU 133A
chips [52]. A matrix plot of normalized log-intensities was
used to visualize the degree of difference in TGF-𝛽 responsive
genes between muscular tissue transcriptomes harvested
from curve concavity and convexity in both groups. The
main purpose of the matrix plot is to obtain an overview of
the correlation between conditions in the dataset and detect
conditions that separate the data into different groups.Higher
intersample differences are interpreted through the distance
of the spots from the regression line. Matrix plot analysis of
the expression data highlighted a greater number of up- and
downregulated genes in the paravertebral muscles of group
A (AM1 versus AM2) compared to group B, where these
differences were less pronounced. The matrix plot generated
also indicates greater differences in TGF-𝛽 responsive gene
expression at the mRNA level between groups A and B in the
specimens from the curve concavity (AM1 versus BM1). The
difference was much less clear between the transcriptomes
from the curve convexity (AM2 versus BM2—Figure 3).
Further statistical analysis of the microarray data was
performed by means of two-way ANOVA to test the main
effects of the curve side (M1, M2), and age of scoliosis onset
(A, B), and their interactions.Through this analysis, 144 genes
were identified as having significantly different expression
(𝑃 < 0.05) either with respect to the of the curve side,
the age of scoliosis onset, or both. The Venn diagram in
Figure 4 displays the numbers of these genes products whose
𝑃 values were influenced by each parameter independently
(side of the curve and age of scoliosis onset) and also by the
effect that each of the parameters had on the other. From
a total of 45 genes that displayed a curve side main effect,
31 were significant due to the curve side effect only, while
4 genes displayed the curve side effect and an interaction
effect. Expression of another 58 genes displayed an age of
scoliosis onset effect. Of those, 8 were affected by both side
of the curve and age of onset, but each of the factors affected
gene expression independently one of another. In the case
of 51 genes that were statistically significant neither with the
regard to the side of the curve, nor to the age of scoliosis
onset, the two-way ANOVA test had a 𝑃 value < 0.05 for
the interaction effect. Nine genes were statistically significant
for the age of onset effect and interaction effect but not
the curve side effect. Four genes were statistically significant
with regard to the side of the curve effect and interaction
effect. Two genes displayed all the three effects: side of the
curve, age of onset and interaction (Figure 4). Interaction
effects indicate that there is no overall effect, but rather
an effect that changes with the levels of another variable.
As it is dangerous to interpret main effects when a gene
shows an interaction effect, further statistical analyses were
performed with nonparametric 𝑈 Mann-Whitney test, with
permutative 𝑃-value computation type (100 permutations).
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Figure 2: Evaluation of the transcriptional profile of TGF-𝛽s and their receptors TGFBRs in paravertebral muscles of JIS group A and AIS
group B by qRT-PCR. Box and whisker plots illustrating statistically significant (nonparametric 𝑈Mann-Whitney test, 𝑃 < 0.05) results of
the comparison of the mRNA abundance of TGF-𝛽s and TGFBRs between concave and convex sides of the curve in both analyzed groups.
AM1, AM2, respectively, paravertebral muscle of concave and convex side of the curve in JIS group and BM1, BM2 samples from concave and
convex side of the curve in AIS group.
Fold change with a cutoff > 1 and 𝑃 < 0.05 was assumed
to be statistically significant. In consequence, a group of 44
mRNA IDs of TGF-𝛽 related genes differentially expressed
betweenM1 andM2 paravertebral muscles was selected from
groupA and 34mRNA IDs fromgroupB. Further selection of
differentially expressed genes was performed by comparison
of the results of the two-way ANOVA and nonparametric
𝑈 Mann-Whitney tests. Only those genes that fulfilled the
criteria of statistical significance in both tests were considered
for GO classification. A total of 24 genes (10 upregulated and
14 downregulated) differentiating paravertebral M1 and M2
transcriptomes were selected from group A and 11 genes (7
upregulated and 4 downregulated) from group B. Selected
genes were subsequently classified by their GO molecu-
lar function through the open access PANTHER database
(Table 4). Both lists of differentiating genes were subse-
quently divided into upregulated and downregulated groups
and further analyzed statistically using an overrepresentation
test; a binominal statistical tool that takes a list of genes and
finds PANTHER functional classes that are overrepresented
or underrepresented in the list compared with a selected
reference list of genes [51]. Overrepresentation test analysis
was performed in terms of GOmolecular function, biological
process and cellular component with the use of Bonferroni
correction for multiple testing; 𝑃 < 0.05 was considered sta-
tistically significant.The reference list comprised 1050mRNA
IDs of 530 TGF-𝛽 related genes that were analyzed withHGU
133A microarray chips. This analysis revealed no statistically
significant results in group A. In addition, in group B no
statistically significant results were found neither in the group
of downregulated genes nor in the group of upregulated genes
in the GO category of biological process. However analysis
of GO molecular function in the group of genes upregulated
in group B showed statistically significant overrepresentation
of genes connected with calmodulin binding (LTBP3, LTBP4,
andMYL6; Figure 5). Analysis of the GO cellular component
localization of the upregulated genes of the group B indicated
statistically significant overrepresentation of genes localized
in the extracellular matrix and extracellular region (LTBP3,
LTBP4, ITGB4, and ITGB5), (Figure 6).
4. Discussion
In two previous studies significantly higher expression of
TGF-𝛽1 was found on the concave side of the curve in
the vertebral cartilaginous endplates and articular cartilages
of the apical articular processes of AIS patients, suggesting
that TGF-𝛽1 is involved either as an etiological factor or a
secondary change in the curve development [53, 54]. In the
first part of this work, gene expression profiling was used
in order to identify differences in the expression of TGF-
𝛽s and their receptors, TGFBRs, between both sides of the
curve in the paravertebral muscles of juvenile and adolescent
idiopathic scoliosis. Significantly higher abundances of TGF-
𝛽2, TGF-𝛽3, and TGFBR2 transcripts were confirmed using
bothmicroarray and qRT-PCR techniques inmuscular tissue
samples collected from the curve concavity of AIS patients.
The expression pattern of TGF-𝛽s and their receptors was
not previously examined in the paravertebral muscles of IS
patients with different ages of deformity onset. Increased
transcriptional activity of TGF-𝛽2, TGF-𝛽3, and TGFBR2
seen on the concave side of the curve in AIS patients might
suggest the involvement of TGF-𝛽 signaling in the pathogen-
esis of scoliotic curves with later onset. However it should be
pointed out that all of the tissue samples were harvested from
patients with severe curves, long after the deformity onset.
The selection of patients with severe idiopathic scoliosis
curves for experimental groups can be problematic because
such patients represent the extreme cases, and at the time of
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Figure 3: TGF-𝛽 responsive genes in the paravertebral muscles of JIS and AIS patients. Matrix plot illustrating the degree of differentiation
of 1050 mRNA IDs of TGF-𝛽 responsive genes between the transcriptomes of muscular tissue in dependence of the side of the curve (M1
versus M2) and the age of scoliosis onset (A versus B). Red spots upregulated genes, blue spots downregulated genes. M1, M2: respectively
muscular tissue samples from curve concavity and convexity, A: juvenile idiopathic scoliosis; B: adolescent idiopathic scoliosis.
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Table 4: GOmolecular functions of TGF𝛽 related genes differentiating muscular transcriptomes from concave and convex sides of the curve
in JIS: juvenile idiopathic scoliosis and AIS: adolescent idiopathic scoliosis. 𝑃 value result of nonparametric 𝑈Mann-Whitney test. FC: fold
change.
Function JIS AIS
Gene 𝑃 FC Regulation Gene 𝑃 FC Regulation
Transcription factor activity
NR3C1 0.04 1.56 up TOX4 0.01 1.17 down
SMAD3 0.02 1.18 up
TRIM33 0.03 1.38 down
ZBTB7B 0.02 1.26 down
Growth factor activity
BMP2K 0.04 1.12 down GDF15 0.03 1.17 up
BMP6 0.02 1.17 down
INHBA 0.01 1.18 down
Receptor activity TACD2 0.02 1.22 down ITGB4 0.01 1.09 up
ITGB5 0.01 1.15 up
Calcium ion binding FKBP1A 0.01 1.37 up
PCDH1 0.01 1.3 down
Calmodulin binding
LTBP3 0.03 2.34 up
LTBP4 0.01 1.5 up
MYL6 0.03 1.53 up
Protein binding FBXL12 0.01 1.31 up
ASPP1 0.02 1.23 down
Hormone activity PTHR 0.02 1.1 down
Cysteine type peptidase activity UCHL5 0.03 1.56 up
Oxidoreductase activity EGLN1 0.04 1.52 up
Str. constituent of cytoskeleton KRT15 0.01 1.26 down
Ubiquitin protein ligase activity SMURF1 0.03 1.04 down
Nucleotide kinase activity MAGI2 0.02 1.2 down
Transmembrane receptor protein-kinase activity TGFBR2 0.01 1.13 up
Unclassified
FA175 0.02 1.26 up
TTC17 0.04 1.21 up
WIPI3 0.02 1.19 up
TMEM1 0.03 1.1 up
UNC45 0.03 1.43 down
DCAF7 0.01 1.23 down
SH3D21 0.01 1.19 down
RAB25 0.01 1.13 down
L1TD1 0.02 1.05 down
the study they are usually much older than, when the curve
started to develop [4].The average age of the deformity onset
(diagnosis) in the JIS groupwas 7.2 years old and inAIS group
12.5. The average age of patients at the time of the operative
treatment, when the tissue specimens were collected, was 17.9
years old. Thus it is possible that increased TGF-𝛽 signaling
at the curve concavity was also present in the JIS group
but earlier in the curve evolution. Differences in TGF-𝛽2,
TGF-𝛽3 and TGFBR2 expression between JIS and AIS may
need definitive confirmation by histological staining. Despite
the similarity of their actions in vitro, each of the TGF-𝛽
isoforms appears to mediate a different set of actions in vivo.
Knocking out TGF-𝛽1, TGF-𝛽2, and TGF-𝛽3 in mice has
shown no phenotypic overlap, indicating that these isoforms
are functionally noncompensated [21, 23, 55]. The difference
in the expression of TGF-𝛽2, TGF-𝛽3 and TGFBR2 observed
between the sides of the curve in the AIS group may be a
secondary phenomenon in the scoliosis progression, reflect-
ing an increase in the extent of fibrotic changes to the curve
concavity; as TGF-𝛽s are considered critical regulators of
physiological fibrogenesis and pathological fibrosis. TGF-𝛽1
and TGF-𝛽2 are potent profibrotic factors, whereas TGF-𝛽3
reduces the fibrotic response. It seems that TGF-𝛽2 is secreted
only at the initial stage of fibrosis as an assistant factor toTGF-
𝛽1.The ratio TGF-𝛽1/TGF-𝛽3 is also of importance andmight
influence the progression of the fibrotic response [12, 56].
Stimulating cells with TGF-𝛽s immediately leads to positive
and negative changes in the expression of several hundred
genes. Many of these gene responses depend on the cell type
and other conditions affecting the cell at the time of TGF-𝛽
BioMed Research International 9
8 39
2
94
51
31
M1 versus M2
45 mRNA
A versus B
58 mRNA
(M1 and M2) versus (A and B)
66 mRNA
Figure 4: Venn diagram of two way ANOVA test for TGF-𝛽
responsive genes. Venn diagram illustrating the number of TGF-
𝛽 responsive genes with a 𝑃 value < 0.05 (two way ANOVA)
differentially expressed between the sides of the curve (M1 versus
M2), age of scoliosis onset (A versus B) and their interactions.
stimulation [57, 58].Thedifferences in the expression of TGF-
𝛽 isoforms and their receptors observed in this study between
the concave and convex sides of the curve may suggest
different role of TGF-𝛽 signaling in juvenile and adolescent
idiopathic curves. This could be reflected by differences in
the transactivation of TGF-𝛽 responsive genes. Thus, in the
second part of this work we analyzed paravertebral muscle
transcriptomes from JIS and AIS individuals in order to
identify the TGF-𝛽 responsive genes that are differentially
expressed between the concave and convex sides of the
curve. Statistical analysis of the expression profile of 1050
mRNA probes of 530 TGF-𝛽 responsive genes permitted
the selection of 10 upregulated and 14 downregulated can-
didate genes in JIS and 7 upregulated and 4 downregulated
genes in AIS. There was no overlap between differentially
expressed TGF-𝛽 related genes in the JIS and AIS groups.
This observation supports the idea of differences in the
involvement of TGF-𝛽 signaling in paravertebral muscles of
IS patients with different ages of onset. The results of the
overrepresentation test were statistically significant only in
the AIS group of upregulated genes for the categories of
GO molecular function and GO cellular component. In the
category of GO molecular function statistically significant
overrepresentation of genes involved in calmodulin binding
was revealed: Myosin light polypeptide 6 (MYL6), latent
transforming growth factor beta binding protein 3 (LTBP3),
and latent transforming growth factor 𝛽 binding protein 4
(LTBP4). The significant overexpression of genes involved in
calmodulin binding seems to be interesting in the context
of some previous studies concerning IS. It has been shown
that an increased calmodulin concentration in platelets is
associated with progression of AIS [59, 60]. The platelet
calmodulin changes were attributed to paravertebral muscle
activity, and a role for calmodulin in the etiopathogenesis
of IS as a systemic mediator of tissues with contractile
properties was suggested [60]. In animal models of IS admin-
istration of tamoxifen, a calmodulin antagonist, appeared
to decrease the magnitude and incidence of the deformity
[61, 62]. Examination of paravertebral muscles of patients
undergoing surgery for AIS revealed higher concentrations
of calmodulin in muscle specimens of the curve convexity
[63]. Myosin light polypeptide 6 is a smooth muscle and
nonmuscle myosin light chain encoded by the MYL6 gene,
located on chromosome 12q13.2. MYL6 protein is one of the
two essential light chains of the actin-based motor protein
complex of myosin. The functional roles of the essential light
myosin chains in the smoothmuscle are not fully understood.
It is likely that these proteins affect the interaction between
the two myosin heads when the regulatory light chains are
phosphorylated [64, 65]. It has been suggested that the type
of the essential myosin light chain influences the maximal
shortening velocity in smooth muscles [66]. Expression of
MYL6 in human skeletal muscles has been confirmed by
microarray investigations [67]. The role of MYL6 upregu-
lation observed in the paravertebral muscles of the curve
concavity in the pathogenesis of the scoliotic deformity in the
AIS group remains to be elucidated. The protein products of
TGF-𝛽1–3 genes are secreted from cells to the extracellular
space and maintained in an inactive form in a complex
with latency associated polypeptide (LAP) and latent TGF-𝛽
binding proteins (LTBPs) [21]. LTBPs are large glycoproteins
structurally related to fibrillin. Through interactions with
divergent proteins, LTBPs affect the bioavailability of TGF-
𝛽s and play an important structural role in elastic fibril and
microfibril organization and function [23, 66, 68]. Four dif-
ferent LTBPs are known, of which LTBP3 binds all three TGF-
𝛽 LAP isoforms with high affinity, whereas LTBP4 shows a
weak binding capacity only for TGF-𝛽1 LAP [23, 69]. LTBP3
can also associate with a pro-form of myostatin, a TGF-𝛽-
like hormone that regulates the size of skeletal muscles [23].
Larger back muscle volume at the concave side of the curve
apex in AIS patients has been confirmed by MRI data [70].
LTBP4 is highly expressed in skeletal muscle and has been
postulated to be a determinant of damage and fibrosis in
muscle diseases [71]. Studies in humans and mice show that
LTBP4 performs a functional role in promoting elastogenesis
and in regulating TGF-𝛽 activity [68]. Integrity of the
structures stabilizing the spine, including the paravertebral
muscles, depends to a large degree on the constituents of
the extracellular matrix and their response to biomechanical
load. Immunohistochemical studies on ligamentum flavum
specimens from patients with AIS revealed pathological
changes in the elastic fibers of the microfibrils [26]. Defects
in the elastic fiber system may result in spinal imbalance
and lead to spinal deformity. Elastic proteins have been
observed in spinal connective tissues as well as in the muscle
and bone matrix of scoliotic patients [72]. The upregulation
of LTBP3 and LTBP4 seen in this study may suggest that
these proteins, as important ECM components, could play an
important role in the pathogenesis of AIS. This was further
supported by GO cellular component overrepresentation test
results. Statistically significant overrepresentation of genes
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Figure 5: Overrepresentation test of upregulated genes differentiating muscular transcriptomes in JIS and AIS—GO molecular function.
Overlaid area chart of difference presenting the results of an overrepresentation test of GO molecular function of upregulated genes
differentiating concave and convex paravertebral muscle transcriptomes in JIS and AIS group. ∗ above the peak mark statistically significant
result of overrepresentation test, 𝑃 < 0.05 calculated with Bonferroni multiple correction.
localized in the ECM and extracellular region was found.
In addition to LTBP3 and LTBP4, statistical analysis high-
lighted two other upregulated genes that were differentially
expressed in the concave and convex sides of the curve in
the AIS group: integrin beta4 (ITGB4), and integrin beta5
(ITGB5). The ECM is a complex three-dimensional network
of macromolecules secreted and deposited into the space
surrounding cells [28]. The ECM regulates cell behavior by
acting as a substrate for cell migration, modulating growth
factor activity, transmitting signals and serving as a structural
framework necessary for normal structural integrity [24, 73].
Integrins are heterodimeric transmembrane receptors that
attach cells to the surrounding ECM and mediate both cell-
cell and cell-ECM interactions. These proteins play a role in
bidirectional signaling across the cell membrane in order to
regulate cell adhesion, migration, and proliferation as well
as differentiation and extracellular matrix remodeling. Addi-
tionally, integrins can modulate the signaling pathways of
many growth factors, including TGF-𝛽s [74–78]. In humans,
each of the 24 known integrins is composed of one of 18 alpha
subunits and one of 8 beta subunits. Each subunit contains
a large extracellular domain, a transmembrane region, and
a cytoplasmic tail [77, 78]. The combination of subunits
determines the specificity of integrins for ECMmolecules [76,
79, 80]. The extracellular domains bind with ECM proteins
such as fibronectin, laminin and collagen. The cytoplasmic
domains of beta subunits interact with kinases such as focal
adhesion kinase and Src kinase, adaptor molecules like talin
and kindlin and the cytoskeleton (actin and microtubules)
[77]. Integrins also act as mechanotransducers, which sense
tension generated either by cytoskeletal elements or the ECM
[75, 81, 82]. Such integrin-mediated mechanotransduction
plays an important role in remodeling and functional adap-
tation of skeletal muscle tissue to ensure an optimal force
transmission withmuscle contraction [79, 82]. Integrin beta4
(ITGB4), and integrin beta5 (ITGB5) subunits are encoded
by genes located respectively on chromosomes 17q25 and
3q21 [67]. ITGB4 tends to associate with integrin alpha6
subunit and is one of the highly selective receptors of
laminin, a major structural component of the basement
membranes of epithelial tissues [76, 83]. In contrast to the
majority of integrins alpha6beta4 does not connect to the
actin cytoskeleton but to the intermediate filament system
[75, 83]. It appears that, besides its role in stable adhesion,
integrin alpha6beta4 is upregulated in wound healing and
can play the role of master regulator of the expression levels
of the other integrins in the epidermis [84]. Recent studies
show that in skeletal muscle, beta4 integrin marks interstitial
progenitor cells that are distinct from satellite cells but exhibit
myogenic potential [85, 86]. Integrin alphavbeta5 functions
as a major vitronectin receptor and, to lesser extent, as a
fibronectin receptor [76, 79]. TGF-𝛽1 and TGF-𝛽3 can be
activated through their interaction with several integrins,
including alphavbeta5 [74, 76, 78, 87]. Activation of TGF-𝛽 by
alphavbeta5 could be important in pathological conditions,
as illustrated by an increased expression of this integrin in
the dermis of scleroderma patients [84]. Additionally, TGF-𝛽
activation by alphavbeta5 is important in pulmonary fibrosis
[74]. Interestingly, alphavbeta5 is also a molecular marker
for skeletal muscle mononuclear cells, including satellite and
progenitor interstitial cells [79]. The upregulation of ITGB4
and ITGB5 observed in the paravertebralmuscles of the curve
concavity of AIS patients merits further investigation as this
could lead to the disequilibrium between the two sides of
the curve and could be involved in the pathogenesis of AIS.
However caution should be taken when drawing definite
conclusions about the role of ECM macromolecules in the
evolution of scoliotic curves, due to the small number of
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Figure 6: Overrepresentation test of upregulated genes differen-
tiating muscular transcriptomes in AIS—GO cellular component
localization. Bar chart of difference presenting the results of an
overrepresentation test of GO cellular component localization of
upregulated genes differentiating concave and convex paravertebral
muscle transcriptomes in the AIS group. Yellow bars indicate
statistically significant results of overrepresentation test, 𝑃 < 0.05
calculated with Bonferroni multiple correction.
specimens analyzed in this study and the lack of a control
group. Our results may need validation in another popula-
tion with larger sample size. The exact genetic mechanisms
that contribute to spinal malformation in IS are still to
be unraveled. Neuromuscular abnormalities, in conjunction
with adverse mechanical environments, in which hormonal
and other chemical factors act as regulators of skeletal
muscle tone and function, are possible explanations for the
pathogenesis of IS [88]. The interactions between different
cell types of the neuromuscular system are mainly mediated
by diffusible factors, many of which are growth factors like
TGF-𝛽s [89]. Further molecular research is needed to deter-
mine whether interactions between growth factor signaling
pathways, such as the TGF-𝛽 pathway, and transcriptional
regulatory networks lead to the initiation and progression of
scoliotic deformities. At present, treatment of IS is focused on
symptoms and involves bracing, and surgery in more severe
cases. The identification of proteins and signaling pathways
with significant asymmetry in expression pattern between
concave and convex side of the curve could suggest new
biomarkers of progression risk and aid in developing novel
therapeutics to combat structural changes of the spine.
5. Conclusions
The transcriptional activity of TGF-𝛽2, TGF-𝛽3, and
TGFBR2 and the expression profile of TGF-𝛽 responsive
genes differ in paravertebral muscle transcriptomes depend-
ing on the age of scoliosis onset and the side of the scoliotic
curve. This phenomenon could signify a different involve-
ment of TGF-𝛽 signaling in the pathogenesis of juvenile
and adolescent curves. Analysis of TGF-𝛽 responsive genes
that differ in the concave and convex paravertebral muscle
transcriptomes of AIS patients highlights the upreg-ulation
of genes localized in the extracellular region of the concave
side of the curve (LTBP3, LTBP4, ITGB4, and ITGB5). This
finding suggests that the extracellular region of paravertebral
muscles is an interesting target for future molecular research
on AIS pathogenesis.
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